Mirador Capital Partners LP 10x Genomics, Inc. Transaction History

Mirador Capital Partners LP

  • $529 Million
  • Q4 2024

A detailed history of Mirador Capital Partners LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 80,983 shares of TXG stock, worth $1.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
80,983
Previous 58,191 39.17%
Holding current value
$1.2 Million
Previous $1.31 Million 11.5%
% of portfolio
0.22%
Previous 0.24%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025
BUY
$13.18 - $21.31 $300,398 - $485,697
22,792 Added 39.17%
80,983 $1.16 Million
Q3 2024

Oct 04, 2024
SELL
$15.71 - $23.49 $59,320 - $88,698
-3,776 Reduced 6.09%
58,191 $1.31 Million
Q2 2024

Jul 12, 2024
BUY
$19.45 - $37.37 $644,611 - $1.24 Million
33,142 Added 114.98%
61,967 $1.21 Million
Q1 2024

Apr 17, 2024
BUY
$36.08 - $54.3 $33,915 - $51,042
940 Added 3.37%
28,825 $1.08 Million
Q4 2023

Jan 19, 2024
BUY
$34.32 - $57.55 $17,880 - $29,983
521 Added 1.9%
27,885 $1.56 Million
Q3 2023

Oct 05, 2023
SELL
$40.86 - $62.98 $183,052 - $282,150
-4,480 Reduced 14.07%
27,364 $1.13 Million
Q2 2023

Aug 14, 2023
SELL
$50.96 - $58.72 $61,406 - $70,757
-1,205 Reduced 3.65%
31,844 $1.78 Million
Q1 2023

Apr 14, 2023
BUY
$35.33 - $55.79 $228,867 - $361,407
6,478 Added 24.38%
33,049 $1.84 Million
Q4 2022

Feb 09, 2023
SELL
$24.4 - $41.3 $41,724 - $70,623
-1,710 Reduced 6.05%
26,571 $968,000
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $358,477 - $661,950
12,587 Added 80.2%
28,281 $805,000
Q2 2022

Aug 05, 2022
SELL
$36.95 - $82.41 $231,048 - $515,309
-6,253 Reduced 28.49%
15,694 $710,000
Q1 2022

May 06, 2022
BUY
$55.7 - $145.79 $25,844 - $67,646
464 Added 2.16%
21,947 $1.67 Million
Q4 2021

Feb 02, 2022
BUY
$135.05 - $182.59 $182,722 - $247,044
1,353 Added 6.72%
21,483 $3.2 Million
Q3 2021

Nov 09, 2021
BUY
$145.58 - $192.14 $657,876 - $868,280
4,519 Added 28.95%
20,130 $2.93 Million
Q2 2021

Jul 27, 2021
BUY
$134.22 - $202.37 $191,263 - $288,377
1,425 Added 10.05%
15,611 $3.06 Million
Q1 2021

Apr 29, 2021
SELL
$140.25 - $196.86 $26,787 - $37,600
-191 Reduced 1.33%
14,186 $2.57 Million
Q4 2020

Jan 20, 2021
BUY
$126.47 - $163.7 $118,628 - $153,550
938 Added 6.98%
14,377 $2.04 Million
Q3 2020

Nov 12, 2020
BUY
$87.44 - $125.0 $51,414 - $73,500
588 Added 4.58%
13,439 $1.68 Million
Q2 2020

Aug 06, 2020
BUY
$58.39 - $89.31 $32,523 - $49,745
557 Added 4.53%
12,851 $1.15 Million
Q1 2020

May 11, 2020
BUY
$51.57 - $106.62 $412,250 - $852,320
7,994 Added 185.91%
12,294 $968,000
Q4 2019

Jan 17, 2020
BUY
$46.07 - $79.54 $198,101 - $342,022
4,300 New
4,300 $328,000

Others Institutions Holding TXG

# of Institutions
295
Shares Held
96.6M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.41B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Mirador Capital Partners LP Portfolio

Follow Mirador Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email